N@N

HEB, LTS, BDX, AMRI, TLP, GGB Expected To Be Down Before Next Earnings Releases

October 18, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Hemispherx Biopharma Inc (AMEX:HEB), LADENBURG THALMANN FINANCIAL SERVICES, INC. (AMEX:LTS), Becton Dickinson and Co (NYSE:BDX), Albany Molecular Research Inc (NASDAQ:AMRI), Transmontaigne Partners LP (NYSE:TLP), Gerdau SA (NYSE:GGB) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Thursday:

  Symbol  Company                          # of Reports         Quarter  Release Date
  HEB     Hemispherx Biopharma Inc         6 Quarter            Q3       11/08/2012
  LTS     LADENBURG THALMANN FINANCIAL SERVICES, INC.  6 Quarter            Q3       11/08/2012
  BDX     Becton Dickinson and Co          November Earnings    Q4       11/07/2012
  AMRI    Albany Molecular Research Inc    November Earnings    Q3       11/06/2012
  TLP     Transmontaigne Partners LP       November Earnings    Q3       11/06/2012
  GGB     Gerdau SA                        6 Quarter            Q3       11/01/2012

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Hemispherx Biopharma Inc (AMEX:HEB) - Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The companys products include Ampligen, an experimental drug that is under clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, Hepatitis B, human immunodeficiency virus, renal cell carcinoma, and malignant melanoma; and Alferon N Injection for the treatment of genital warts. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and other emerging viral diseases; and Oragens, a set of oral broad spectrum antivirals and immunological enhancers for the treatment of chronic viral and immunological disorders. The company has a strategic alliance with Accredo to develop certain marketing and distribution capacities for Ampligen in the United States. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania..

LADENBURG THALMANN FINANCIAL SERVICES, INC. (AMEX:LTS) - Ladenburg Thalmann Financial Services Inc., through its subsidiaries, provides a range of financial services primarily to corporate and institutional clients, and high net-worth individuals in the United States. The company offers investment banking, equity research, institutional sales and trading, independent brokerage, advisory, and asset management services. It operates as a full-service investment bank that provides corporate finance, strategic and financial advisory services, sales and trading, and equity research services. The company offers a range of financing options, including underwritten public offerings, registered direct offerings, at-the-market offerings, private investment in public equity, and other private placements. It also provides asset management, investment consulting, private investment management, retirement plan sponsor, alternative investments, and third party advisory services. In addition, the company offers securities brokerage and advisory services, and a range of packaged products comprising mutual funds, variable annuities, advisor managed accounts, and third party managed accounts. Further, it provides wealth management services, including trust administration, estate and financial planning, and custody and investment services. Ladenburg Thalmann Financial Services Inc. was founded in 1876 and is headquartered in Miami, Florida..

Becton Dickinson and Co (NYSE:BDX) - Becton, Dickinson and Company (BD), a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The companys BD Medical segment produces medical devices for use in various healthcare settings. This segments products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs to treat diabetes; prefillable drug delivery systems; anesthesia needles and trays; and sharps disposal containers. Its BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect various infectious diseases, healthcare-associated infections (HAI), and cancers. This segments products consist of integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for sexually transmitted diseases and HAIs; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; and plated media. The companys BD Biosciences segment produces research and clinical tools that facilitate the study of cells and their components. This segments products comprise fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. BD markets its products to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public through independent distribution channels and independent sales representatives. The company was founded in 1897 and is based in Franklin Lakes, New Jersey..

Albany Molecular Research Inc (NASDAQ:AMRI) - Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers drug discovery services, including assay development and design; screening programs, which provide tools to identify active compounds during the lead discovery phases of drug discovery; screening libraries for screening and hit-to-lead programs; bioanalytical services for extraction and quantitation of drug and metabolites in biological fluids and tissues; and natural product services. Its drug discovery services also include medicinal chemistry; computer-aided drug discovery services to identify novel hits or leads against selected therapeutic targets, as well as to support medicinal chemistry lead optimization programs; and in vitro ADMET assays to evaluate and improve metabolism, bioavailability, pharmacology, and toxicology of compounds. The company also provides chemical development services, such as process research and development; custom synthesis; process safety assessment; high potency and controlled substances; preparative chromatography; IND support services; fermentation development and optimization; and building blocks collection and database, as well as offers chemical synthesis and manufacturing services in accordance with cGMP regulations, and formulation services. In addition, it provides analytical services, including impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; and regulatory support, as well as offers chemical synthesis and manufacturing services. The company also serves agricultural and fine chemical companies, contract chemical manufacturers, government research entities, and non-profit organizations. Albany Molecular Research was founded in 1991 and is based in Albany, New York..

Transmontaigne Partners LP (NYSE:TLP) - TransMontaigne Partners L.P. operates as a terminaling and transportation company. It provides integrated terminaling, storage, transportation, and related services for customers engaged in the distribution and marketing of light refined petroleum products, heavy refined petroleum products, crude oil, chemicals, fertilizers, and other liquid products. The company operates along the Gulf Coast, in the Midwest, in Brownsville, Texas, along the Mississippi and Ohio Rivers, and in the southeastern United States. As of December 31, 2010, it operated 7 refined product terminals in Florida with an aggregate storage capacity of approximately 7.1 million barrels; a 67-mile interstate refined products pipeline between Missouri and Arkansas and 3 refined product terminals with approximately 0.6 million barrels of aggregate active storage capacity; 2 refined product terminals located in Mt. Vernon, Missouri, as well as Rogers, Arkansas with an aggregate active storage capacity of approximately 407,000 barrels; and 1 refined product terminal in Oklahoma City, Oklahoma with an aggregate active storage capacity of approximately 158,000 barrels. The company also operated 1 refined product terminal in Brownsville, Texas with an aggregate active storage capacity of approximately 2.2 million barrels; 1 refined product terminal located in Matamoros, Mexico with an aggregate active LPG storage capacity of approximately 7,000 barrels; a pipeline from Brownsville facilities to its terminal in Matamoros, Mexico; 12 refined product terminals along the Mississippi and Ohio rivers with an aggregate active storage capacity of approximately 2.5 million barrels, as well as a dock facility; and 22 refined product terminals along the Colonial and Plantation pipelines with an aggregate active storage capacity of approximately 9.3 million barrels. TransMontaigne GP L.L.C. serves as the general partner of the company. TransMontaigne Partners L.P. was founded in 2005 and is based in Denver, Colorado..

Gerdau SA (NYSE:GGB) - Gerdau S.A. engages in the production and sale of steel products in Brazil and internationally. The company offers crude steel products, which include billets that are used to manufacture wire rods, rebars, and merchant bars; blooms for use in the manufacture of springs, forged parts, heavy structural shapes, and seamless tubes; and slabs, which are used in the steel industry for the rolling of various flat rolled products, as well as to produce hot and cold rolled coils, heavy slabs, and profiles. Its long rolled products include rebars, merchant bars, and profiles, which are used in construction and manufacturing industries; and drawn products comprise barbed and barbless fence wire, galvanized wire, fences, concrete reinforcing wire mesh, nails, and clamps for manufacturing, construction, and agricultural sectors. The company also offers specialty and stainless steel products used in tools and machinery, chains, fasteners, railroad spikes, and special coil steel, as well as special sections, such as grader blades, smelter bars, light rails, super light I-beams, and elevator guide rails. In addition, it provides flat products, such as hot and cold steel coils, heavy plates, and profiles; and resells flat steel products manufactured by other Brazilian steel producers. The company, through its interest in Dona Francisca Energetica S.A., operates a hydroelectric power plant with a nominal capacity of 125 megawatts located in Agudo, Rio Grande do Sul state. It has strategic partnerships with Multisteel Business Holdings Corp. and Corporacin Centroamericana del Acero S.A. The company was founded in 1901 and is based in Porto Alegre, Brazil. Gerdau S.A. operates as a subsidiary of Metalurgica Gerdau S.A..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641